Cite
HARVARD Citation
Lu, B. et al. (2023). Piperacillin/tazobactam versus cefepime or carbapenems for cefoxitin-non-susceptible Enterobacter cloacae, Klebsiella aerogenes, Citrobacter freundii, Serratia marcescens and Morganella morganii bacteraemia in immunocompromised patients. Journal of antimicrobial chemotherapy. pp. 1009-1014. [Online].